These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17475725)

  • 21. Background and design of a controlled clinical trial (ARC 090) for the treatment of opioid dependence.
    Johnson RE; Fudala PJ
    NIDA Res Monogr; 1992; 128():14-24. PubMed ID: 1436012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
    Jain RB
    NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
    [No Abstract]   [Full Text] [Related]  

  • 24. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
    Connery HS
    Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
    Kosten TR; Morgan C; Kleber HD
    NIDA Res Monogr; 1992; 121():101-19. PubMed ID: 1406906
    [No Abstract]   [Full Text] [Related]  

  • 26. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children's hospital-based outpatient treatment program.
    Levy S; Vaughan BL; Angulo M; Knight JR
    J Adolesc Health; 2007 May; 40(5):477-82. PubMed ID: 17448411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine for benzodiazepine-abusing heroin addicts.
    KOSTEN TR
    Am J Psychiatry; 1994 Jan; 151(1):151. PubMed ID: 8267120
    [No Abstract]   [Full Text] [Related]  

  • 31. Three estimators of the probability of opiate use from incomplete data.
    Gross AJ
    NIDA Res Monogr; 1992; 128():82-94; discussion 95-6. PubMed ID: 1436018
    [No Abstract]   [Full Text] [Related]  

  • 32. [Maintenance treatment for opiate dependence. Which should we deliver and how should we prescribe it?].
    Jacquiez O
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S55-7. PubMed ID: 12910035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
    Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
    Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.
    Koch AL; Arfken CL; Schuster CR
    Drug Alcohol Depend; 2006 Jul; 83(3):274-8. PubMed ID: 16413146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study.
    Ahmadi J; Ahmadi K; Ohaeri J
    Eur J Clin Invest; 2003 Sep; 33(9):824-9. PubMed ID: 12925043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.